Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Roche”

A Study to Evaluate Glofitamab as Single Agent Administered After Pretreatment With Obinutuzumab in Chinese Patients With Relapsed/Refractory Diffuse Large B-Cell LymphomaCompleted
NCT04657302Phase 1Updated Jan 19, 2024
Sponsor: Hoffmann-La Roche
Lymphoma
China
A Study to Evaluate the Safety and Tolerability of Long-term Administration of Gantenerumab in Participants With Alzheimer's Disease (AD)Terminated
NCT04339413Phase 3Updated Jan 18, 2024
Sponsor: Hoffmann-La Roche
Alzheimer Disease
United States, Argentina, Australia, Canada, Chile +12 more
A Study Of The Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab Vs Aflibercept Treat & Extend In Subjects With Neovascular Age-Related Macular DegenerationWithdrawn
NCT05126966Phase 3Updated Jan 18, 2024
Sponsor: Hoffmann-La Roche
Neovascular Age-Related Macular Degeneration
Argentina, Denmark, Greece, Hong Kong, Portugal +2 more
Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)Terminated
NCT03443973Phase 3Updated Jan 17, 2024
Sponsor: Hoffmann-La Roche
Alzheimer Disease
United States, Argentina, Belgium, Chile, Croatia +14 more
COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2Terminated
NCT05075538Phase 4Updated Jan 17, 2024
Sponsor: Jules Bordet Institute
Cancer
Belgium
Davos Alzheimer's Collaborative Healthcare System Preparedness to Increase Cognitive Assessment Rates for Older AdultsUnknown
NCT06191952NAUpdated Jan 11, 2024
Sponsor: Ludwig-Maximilians - University of Munich
Subjective Cognitive Decline · Alzheimer Dementia
Germany
Persistent Postpartum Cardiovascular Dysfunction in Patients With PreeclampsiaCompleted
NCT04063397N/AUpdated Jan 10, 2024
Sponsor: Ohio State University
Preeclampsia Severe or Mild · Cardiac Complication
United States
A Study of Ocrelizumab in Participants With Primary Progressive Multiple SclerosisCompleted
NCT01194570Phase 3Updated Jan 10, 2024
Sponsor: Hoffmann-La Roche
Multiple Sclerosis, Primary Progressive
United States, Australia, Austria, Belgium, Brazil +24 more
A Study of Pralsetinib Versus Standard of Care (SOC) for Treatment of RET-Mutated Medullary Thyroid Cancer (MTC).Withdrawn
NCT04760288Phase 3Updated Jan 5, 2024
Sponsor: Hoffmann-La Roche
Medullary Thyroid Cancer
Spain
Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19Terminated
NCT04889040Phase 3Updated Jan 5, 2024
Sponsor: Hoffmann-La Roche
COVID-19
Argentina, Belgium, Brazil, Denmark, Germany +7 more
Olaparib and Bevacizumab in Relapsed Small Cell Lung Cancer SubjectsCompleted
NCT04939662Phase 2Updated Jan 2, 2024
Sponsor: Se-Hoon Lee
Lung Cancer
South Korea
A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast CancerCompleted
NCT03674112Phase 2Updated Jan 2, 2024
Sponsor: Hoffmann-La Roche
HER2-Positive Early Breast Cancer
United States, Argentina, Brazil, Chile, Cuba +12 more
A Study of Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)Completed
NCT02600897Phase 1, Phase 2Updated Dec 26, 2023
Sponsor: Hoffmann-La Roche
Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma
United States, Spain, United Kingdom
Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical CancerCompleted
NCT04405349Phase 2Updated Dec 15, 2023
Sponsor: Nykode Therapeutics ASA
Cervical Cancer · Cervix Cancer
Belgium, Bulgaria, Czechia, Germany, Norway +1 more
A Cross-over Study Examining the Bioequivalence of 3 Test Formulations to a Reference Formulation of Alectinib (RO5424802) in Healthy VolunteersCompleted
NCT02074553Phase 1Updated Dec 11, 2023
Sponsor: Hoffmann-La Roche
Healthy Volunteer
United States
An Extension Study of WA19926 of the Long-Term Safety of Tocilizumab (RoActemra/Actemra) in Patients With Early Moderate to Severe Rheumatoid ArthritisCompleted
NCT01664598Phase 3Updated Dec 11, 2023
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
Russia
Home Monitoring of Adult Patients With SMA: a Pilot Multicenter Validation StudyUnknown
NCT05839145NAUpdated Dec 1, 2023
Sponsor: Institut de Myologie, France
Muscular Atrophy, Spinal, Type II · Muscular Atrophy, Spinal, Type III
France
An Efficacy and Safety Study of Subcutaneous Tocilizumab in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Participants With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current Disease-Modifying Antirheumatic Drug (DMARD) TherapyCompleted
NCT03155347Phase 3Updated Nov 28, 2023
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
China
SARS-CoV-2 (COVID-19) Antibody PrevalencE in an Adult London HIV CohortCompleted
NCT05067400N/AUpdated Nov 27, 2023
Sponsor: Royal Free Hospital NHS Foundation Trust
HIV-1-infection · SARS-CoV Infection · Covid19
United Kingdom
A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132)Completed
NCT02657434Phase 3Updated Nov 21, 2023
Sponsor: Hoffmann-La Roche
Non-Small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +22 more
Concordance of the IHC4 Score Performed in Local or Central Laboratory to Endopredict in ER+/HER2- Breast CancerCompleted
NCT04246606N/AUpdated Nov 18, 2023
Sponsor: UNICANCER
Breast Neoplasm Female
France
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Colorectal Cancer (Morpheus-CRC)Terminated
NCT03555149Phase 1, Phase 2Updated Nov 7, 2023
Sponsor: Hoffmann-La Roche
Colorectal Cancer
United States, Australia, France, South Korea, Switzerland
Mosunetuzumab for Early Relapse of Follicular Lymphoma in the Nordic CountriesRecruiting
NCT05849857Phase 2Updated Nov 1, 2023
Sponsor: Oslo University Hospital
Lymphoma, Follicular
Finland, Norway
A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.Completed
NCT03840200Phase 1Updated Oct 30, 2023
Sponsor: Hoffmann-La Roche
Breast Cancer · Prostate Cancer · Ovarian Cancer
United States, Australia, Italy, South Korea, Spain
Parental Perception of Their Child's Emotional Quality of Life in Paediatric Oncology Before and After "Magic Massages"Unknown
NCT06107478N/AUpdated Oct 30, 2023
Sponsor: Centre Leon Berard
Acute Lymphoblastic Leukemia, Pediatric

Previous page Next page